LIPOPREDICT: Prediction of patients’ response to liposomal antineoplastic drugs: Focusing on the endocytic activity of LRP1B (Q2906914): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Removed claim: co-financing rate (P837): 66.0 percent, Removing co-finance rate from projects in portugal) |
||||||
| Property / co-financing rate | |||||||
| |||||||
| Property / co-financing rate: 66.0 percent / rank | |||||||
Revision as of 11:40, 14 September 2021
Project Q2906914 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | LIPOPREDICT: Prediction of patients’ response to liposomal antineoplastic drugs: Focusing on the endocytic activity of LRP1B |
Project Q2906914 in Portugal |
Statements
203,732.7 Euro
0 references
15 July 2018
0 references
14 July 2021
0 references
IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
0 references
Q2993205 (Deleted Item)
0 references
41°8'58.02"N, 8°36'38.84"W
0 references
Porto
0 references
Identifiers
POCI-01-0145-FEDER-031520
0 references